S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Generative AI boosts UiPath; analysts see triple-digit EPS growth
3 biotech powerhouses poised to thrive amid sector rebound
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

DENTSPLY SIRONA (XRAY) Competitors

$31.88
-0.60 (-1.85%)
(As of 12/8/2023 ET)
Compare
Today's Range
$31.77
$32.64
50-Day Range
$27.25
$33.78
52-Week Range
$26.27
$43.24
Volume
3.56 million shs
Average Volume
2.22 million shs
Market Capitalization
$6.75 billion
P/E Ratio
N/A
Dividend Yield
1.76%
Price Target
$38.89

XRAY vs. NVST, EXEL, ACHC, GRFS, NTRA, CTLT, EHC, THC, SWAV, and BRBR

Should you be buying DENTSPLY SIRONA stock or one of its competitors? The main competitors of DENTSPLY SIRONA include Envista (NVST), Exelixis (EXEL), Acadia Healthcare (ACHC), Grifols (GRFS), Natera (NTRA), Catalent (CTLT), Encompass Health (EHC), Tenet Healthcare (THC), Shockwave Medical (SWAV), and BellRing Brands (BRBR). These companies are all part of the "medical" sector.

DENTSPLY SIRONA vs.

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings.

In the previous week, DENTSPLY SIRONA had 7 more articles in the media than Envista. MarketBeat recorded 7 mentions for DENTSPLY SIRONA and 0 mentions for Envista. Envista's average media sentiment score of 0.60 beat DENTSPLY SIRONA's score of 0.00 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company Overall Sentiment
Envista Neutral
DENTSPLY SIRONA Positive

Envista has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 1.2% of Envista shares are owned by insiders. Comparatively, 0.8% of DENTSPLY SIRONA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Envista currently has a consensus price target of $34.63, suggesting a potential upside of 47.59%. DENTSPLY SIRONA has a consensus price target of $38.89, suggesting a potential upside of 21.99%. Given DENTSPLY SIRONA's higher probable upside, equities research analysts clearly believe Envista is more favorable than DENTSPLY SIRONA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
DENTSPLY SIRONA
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.58B1.56$243.10M$1.0821.72
DENTSPLY SIRONA$3.94B1.72-$950M-$1.01-31.56

Envista has a net margin of 7.39% compared to Envista's net margin of -5.44%. Envista's return on equity of 10.91% beat DENTSPLY SIRONA's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista7.39% 7.29% 4.71%
DENTSPLY SIRONA -5.44%10.91%5.25%

DENTSPLY SIRONA received 418 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.13% of users gave DENTSPLY SIRONA an outperform vote while only 45.76% of users gave Envista an outperform vote.

CompanyUnderperformOutperform
EnvistaOutperform Votes
27
45.76%
Underperform Votes
32
54.24%
DENTSPLY SIRONAOutperform Votes
445
61.13%
Underperform Votes
283
38.87%

Summary

DENTSPLY SIRONA beats Envista on 9 of the 16 factors compared between the two stocks.


Get DENTSPLY SIRONA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XRAY vs. The Competition

MetricDENTSPLY SIRONADental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$6.75B$4.07B$4.65B$6.73B
Dividend Yield1.72%1.72%2.94%5.95%
P/E Ratio-31.5616.61130.6714.28
Price / Sales1.721.603,100.49552.85
Price / Cash3.5611.2421.8323.12
Price / Book1.802.724.744.65
Net Income-$950M$18.55M$125.25M$177.22M
7 Day Performance-2.06%-1.70%1.04%0.78%
1 Month Performance16.99%7.38%10.46%9.25%
1 Year Performance5.35%-19.25%9.56%8.23%

DENTSPLY SIRONA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
2.5442 of 5 stars
$23.70
-1.8%
$34.63
+46.1%
-28.6%$4.06B$2.58B21.9412,700Positive News
EXEL
Exelixis
2.8938 of 5 stars
$21.87
-2.5%
$25.44
+16.3%
+33.2%$6.80B$1.77B78.111,223
ACHC
Acadia Healthcare
2.126 of 5 stars
$74.21
-0.7%
$85.71
+15.5%
-12.1%$6.84B$2.61B-353.3623,000News Coverage
Positive News
GRFS
Grifols
1.9047 of 5 stars
$9.76
+0.5%
N/A+33.5%$6.71B$6.39B0.0026,314Analyst Report
NTRA
Natera
1.9772 of 5 stars
$58.28
-1.7%
$64.00
+9.8%
+50.0%$7.01B$820.22M-12.893,018Insider Selling
Gap Down
CTLT
Catalent
2.5321 of 5 stars
$38.91
-2.7%
$50.45
+29.7%
-18.4%$7.01B$4.28B-7.4319,000Analyst Upgrade
News Coverage
Positive News
EHC
Encompass Health
2.6674 of 5 stars
$65.48
-2.0%
$77.60
+18.5%
+13.6%$6.56B$4.69B18.7135,000Positive News
THC
Tenet Healthcare
2.8957 of 5 stars
$70.17
-3.0%
$84.31
+20.2%
+62.2%$7.13B$20.16B16.21102,400Analyst Downgrade
News Coverage
Positive News
SWAV
Shockwave Medical
3.2405 of 5 stars
$176.35
-1.0%
$263.00
+49.1%
-27.1%$6.51B$671.28M27.471,001
BRBR
BellRing Brands
2.5328 of 5 stars
$54.71
+0.3%
$46.93
-14.2%
+112.1%$7.17B$1.67B44.12380Analyst Report
Positive News

Related Companies and Tools

This page (NASDAQ:XRAY) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -